Curasight

Curasight is a pioneer in the field of exploiting a novel PET imaging target – the urokinase-type plasminogen activator receptor (uPAR) – for improved breast cancer diagnose.

Contact name:

Morten Persson

Address:

Ole Maaløes Vej 3, 2200 Copenhagen, Denmark

If you can't find it here or have feedback to our website, please do not hesitate to contact dd@danskbiotek.dk or 28895854

Copyright 2014 Danskbiotek. All rights reserved.